Balchem Q4 net sales up 9.1% to $232.5M; adjusted EPS $0.94; dividend raised 10.9%

BALCHEM CORP

2022-FY EPS reported $3.25 revenue$942,358,000

Q4 net sales $232.5M (+9.1% YoY); GAAP net earnings $21.4M (-14.2%); adjusted net earnings $30.3M (+9.1%).
Adjusted EBITDA $52.3M (+14.6%); full-year record sales $942.4M (+17.9%) with record sales in all three segments.
Full-year record GAAP EPS $3.25; record adjusted EPS $4.03; operating cash flow $138.5M; free cash flow $89.4M.
Dividend increased 10.9% to $0.71/share, marking 14th consecutive year of double-digit dividend growth.
Net debt $374.0M; leverage ratio 1.7x; repaid $103M revolving debt in 2022.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

BALCHEM CORP reported the quarter ended December 31, 2022 results: revenue $232.5 million, net income $21.4 million, EPS $0.66.

Period: the quarter ended December 31, 2022
Revenue: $232.5 million
Net income: $21.4 million
EPS: $0.66
Result: reported results

Exact text from the filing

Balchem Corporation (NASDAQ: BCPC) reported today fourth quarter net sales of $232.5 million for 2022, compared to net sales of $213.1 million for the fourth quarter 2021. Fourth quarter net earnings were $21.4 million for 2022, compared to net earnings of $24.9 million for the fourth quarter 2021, with adjusted net earnings (a) of $30.3 million, compared to $27.8 million in the prior year quarter.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

BALCHEM CORP reported the year ended December 31, 2022 results: revenue $942.4 million, net income $105.4 million, EPS $3.25.

Period: the year ended December 31, 2022
Revenue: $942.4 million
Net income: $105.4 million
EPS: $3.25
Result: reported results

Exact text from the filing

Balchem Corporation also reported for the full year 2022 net sales of $942.4 million, compared to $799.0 million for 2021. Full year 2022 net earnings were $105.4 million, compared to net earnings of $96.1 million for 2021, with adjusted net earnings of $130.5 million, compared to $116.6 million in the prior year.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

BALCHEM CORP filing history →

Source: SEC EDGAR

accession 0001628280-23-004959

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.